The conference focuses heavily on the various classes of circulating biomarkers and emphasizes the many technology platforms currently being utilized to interrogate Circulating Cell-Free DNA (cfDNA), Circulating Tumor Cells (CTCs) and Extracellular Vesicles (EVs)/Exosomes.
The potential of EVs/Exosomes for Therapeutics Development and Delivery are Presented as well as the Potential of EVs derived from Stem Cells for Regenerative Medicine.
This conference also features a showcase of companies involved in the study of cfDNA, CTCs and Exosomes and technologies in this space.
Korea is an excellent venue for this Asia/Pacific conference with a very strong scientific and technology focus and extensive research in this space plus the excellent conference location in Seoul is accessible from around the world to maximize networking and partnering activities at this conference.
You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 31 August 2019
Circulating Biomarker Classes (Circulating Cell-Free DNA, Circulating Tumor Cells, Exosomes)
Technologies for Isolation and Analysis
Extracellular Vesicles (EVs)/Exosomes
Classes of Biomarkers (RNA, DNA, Protein)
Engineering, Delivery Vehicles and Therapeutics Development
Technologies for Study
Liquid Biopsy Development
Clinical Development and Pipeline
Regulatory Landscape in Asia
Technologies for Implementing using Biofluids
Confirmed Speakers to date
Moon-Chang Baek, Director, Exosome Convergence Research Center (ECRC), Kyungpook National University School of Medicine
Kihwan Kwon, Professor, Ewha Womans University College of Medicine
Yong Weon Yi, Head of Institute, ExoCoBio Exosome Institute, ExoCoBio Inc.
Sponsorship and Exhibition Opportunities
Jeff Fan, Exhibition Manager
For more information, visit the website link below.